13 March 2024>: Articles
A 65-Year-Old Man with Refractory Hemoptysis Associated with Chronic Progressive Pulmonary Aspergillosis Who Failed to Respond to Combined Endobronchial Occlusion and Bronchial Artery Embolization: A Case Report and Literature Review
Management of emergency care
Ryotaro Yoneoka A , Kenichiro Takeda A , Hajime Kasai A* , Toshihiko Sugiura A , Kohei Shikano A , Mitsuhiro Abe A , Takuji Suzuki DDOI: 10.12659/AJCR.942422
Am J Case Rep 2024; 25:e942422
Table 1. Characteristics of the 34 cases of hemoptysis treated with combined endobronchial occlusion and endobronchial Watanabe spigot.
30–39 | 2 (6) |
40–49 | 1 (3) |
50–59 | 3 (9) |
60–69 | 11 (32) |
70–79 | 9 (26) |
80–89 | 8 (24) |
Male | 21 (62) |
Female | 13 (38) |
Primary lung cancer | 8 (24) |
Aspergillus | 6 (18) |
Non-tuberculousmycobacterial infection | 4 (12) |
Bronchiectasis | 3 (9) |
Others | 13 (39) |
EBO alone | 9 (26) |
EBO+combination treatment | |
EBO+BAE | 21 (62) |
EBO+BAE+surgery | 3 (9) |
EBO+surgery | 1 (3) |
Hemostatic success by EWS alone | 9 (26) |
Successful hemostasis with the addition of other treatments | 19 (56) |
Failure of hemostasis | 6 (18) |
Survival | 31 (91) |
Death (including cases other than hemostatic failure) | 3 (9) |
Infections | 2 (6) |
None | 32 (94) |
BAE – bronchial artery embolization; EBO – endobronchial occlusion; EWS – endobronchial Watanabe spigot. |